BR0016064A - Compostos heterocìclicos e seus sais e uso medicinal dos mesmos - Google Patents
Compostos heterocìclicos e seus sais e uso medicinal dos mesmosInfo
- Publication number
- BR0016064A BR0016064A BR0016064-4A BR0016064A BR0016064A BR 0016064 A BR0016064 A BR 0016064A BR 0016064 A BR0016064 A BR 0016064A BR 0016064 A BR0016064 A BR 0016064A
- Authority
- BR
- Brazil
- Prior art keywords
- agent
- hydrogen
- action
- lower alkyl
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
"COMPOSTOS HETEROCìCLICOS E SEUS SAIS E USO MEDICINAL DOS MESMOS". Um composto heterocíclico da fórmula [I] em que R^ 1^ é átomo de hidrogênio ou alquila inferior, R^ 2^ é átomo de hidrogênio, alquila opcionalmente tendo um substituinte e semelhantes, R^ 3^ é átomo de hidrogênio, alquila inferior e semelhantes, A é uma ligação simples ou >N-R^ 5^ em que R^5^ é átomo de hidrogênio ou alquila inferior, B é alquileno inferior, e Y é arila opcionalmente tendo um substituinte e semelhantes, e um seu sal farmaceuticamente aceitável mostram uma ação hipoglicêmica, uma ação hipolipidêmica no sangue, uma ação de melhoramento de resistência à insuluna e uma ação ativadora de PPAR, e são úteis como um agente higoglicêmico, um agente hipolipidêmico, um melhorador de resistência à insulina, um agente terapêutico de diabetes, um agente terapêutico de complicação diabética, um melhorador de tolerância a glicose, um agente de antiaterosclerose, um agente antiobesidade, um agente antiinflamatório, um agente para a profilaxia ou tratamento de doença mediada por PPAR e um agente para a profilaxia ou tratamento de síndrome X.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34554399 | 1999-12-03 | ||
JP2000295108 | 2000-09-27 | ||
PCT/JP2000/008464 WO2001040192A1 (fr) | 1999-12-03 | 2000-11-29 | Nouveaux composes heterocycliques et sels de ces derniers, utilisations de ces composes en medecine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0016064A true BR0016064A (pt) | 2004-07-27 |
Family
ID=26578048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0016064-4A BR0016064A (pt) | 1999-12-03 | 2000-11-29 | Compostos heterocìclicos e seus sais e uso medicinal dos mesmos |
Country Status (21)
Country | Link |
---|---|
US (1) | US6589963B2 (pt) |
EP (1) | EP1236719A4 (pt) |
KR (1) | KR100716525B1 (pt) |
CN (1) | CN1215059C (pt) |
AR (1) | AR033349A1 (pt) |
AU (1) | AU782631C (pt) |
BR (1) | BR0016064A (pt) |
CA (1) | CA2393265A1 (pt) |
CO (1) | CO5440230A1 (pt) |
CZ (1) | CZ20021911A3 (pt) |
HK (1) | HK1053657A1 (pt) |
HU (1) | HUP0203431A3 (pt) |
IL (2) | IL149883A0 (pt) |
MX (1) | MXPA02005528A (pt) |
NO (1) | NO323922B1 (pt) |
NZ (1) | NZ519592A (pt) |
PL (1) | PL356769A1 (pt) |
RU (1) | RU2256661C2 (pt) |
TW (1) | TWI286549B (pt) |
WO (1) | WO2001040192A1 (pt) |
YU (1) | YU50302A (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6455734B1 (en) * | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
EP1911462A3 (en) | 2001-01-26 | 2011-11-30 | Schering Corporation | Compositions comprising a sterol absorption inhibitor |
YU94203A (sh) | 2001-05-29 | 2006-08-17 | Kyoto Pharmaceutical Industries Ltd. | Novi heterociklični derivati i njihova upotreba u medicini |
US7557123B2 (en) | 2001-05-29 | 2009-07-07 | Kyoto Pharmaceutical Industries, Ltd. | Heterocyclic compound and medicinal use thereof |
WO2003059907A1 (fr) * | 2002-01-17 | 2003-07-24 | Takeda Chemical Industries, Ltd. | Composes heterocycliques azotes : procede de preparation et d'utilisation |
DE10222034A1 (de) * | 2002-05-17 | 2003-11-27 | Bayer Ag | Tetrahydroisochinolin-Derivate |
PA8594401A1 (es) * | 2003-02-21 | 2004-09-16 | Pfizer | Acidos carboxilicos de heteroarilo condensado como agonista del ppar |
CN1300115C (zh) * | 2004-03-26 | 2007-02-14 | 厦门大学 | 一种合成1,2,3,4-四氢异喹啉衍生物的方法 |
ES2682282T3 (es) | 2004-10-29 | 2018-09-19 | Kalypsys, Inc. | Compuestos bicíclicos sustituidos con sulfonilo como moduladores de PPAR |
US7790745B2 (en) | 2005-10-21 | 2010-09-07 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline LXR Modulators |
NZ566831A (en) * | 2005-10-25 | 2011-09-30 | Kalypsys Inc | Salts of modulators of PPAR and methods of treating metabolic disorders |
US20080176861A1 (en) | 2007-01-23 | 2008-07-24 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
US20080186971A1 (en) * | 2007-02-02 | 2008-08-07 | Tarari, Inc. | Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic |
WO2009019598A2 (en) * | 2007-08-03 | 2009-02-12 | Dr. Reddy's Laboratories Ltd. | Inhalation therapy for respiratory disorders |
CA2716664C (en) * | 2008-03-07 | 2016-10-11 | Transtech Pharma, Inc. | Oxadiazoanthracene compounds |
AR080374A1 (es) | 2010-03-05 | 2012-04-04 | Sanofi Aventis | Procedimiento para la preparcion de 2-(ciclohexilmetil)-n-(2-((2s)-1-metilpirrolidin-2-il) etil)- 1,2,3,4-tetrahidroisoquinolin-7- sulfonamida |
US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
JPWO2012033195A1 (ja) * | 2010-09-10 | 2014-01-20 | 京都薬品工業株式会社 | 複素環化合物 |
CN102807526B (zh) * | 2011-06-21 | 2015-12-02 | 寿光富康制药有限公司 | 组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用 |
CN102702098A (zh) * | 2012-05-24 | 2012-10-03 | 盛世泰科生物医药技术(苏州)有限公司 | 6-甲氧基-1,2,3,4四氢喹啉-5羧酸甲酯的合成 |
AR101196A1 (es) * | 2014-07-16 | 2016-11-30 | Gruenenthal Gmbh | Compuestos de pirimidina sustituidos |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6051189A (ja) | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
AR240698A1 (es) | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
EP0306228B1 (en) | 1987-09-04 | 1999-11-17 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
US5246943A (en) | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
IL121202A (en) * | 1996-07-01 | 2001-08-26 | Lilly Co Eli | Hypoglycemic and hypolipidemic compounds, process for their preparation, pharmaceutial compositions comprising same, and uses thereof |
ATE277907T1 (de) | 1996-07-01 | 2004-10-15 | Lilly Co Eli | Blutzuckersenkende und lipidsenkende verbindungen |
-
2000
- 2000-11-29 WO PCT/JP2000/008464 patent/WO2001040192A1/ja active IP Right Grant
- 2000-11-29 KR KR1020027007113A patent/KR100716525B1/ko not_active IP Right Cessation
- 2000-11-29 PL PL00356769A patent/PL356769A1/xx not_active Application Discontinuation
- 2000-11-29 BR BR0016064-4A patent/BR0016064A/pt not_active Application Discontinuation
- 2000-11-29 HU HU0203431A patent/HUP0203431A3/hu unknown
- 2000-11-29 RU RU2002117450/04A patent/RU2256661C2/ru not_active IP Right Cessation
- 2000-11-29 CN CNB008165114A patent/CN1215059C/zh not_active Expired - Fee Related
- 2000-11-29 CA CA002393265A patent/CA2393265A1/en not_active Abandoned
- 2000-11-29 MX MXPA02005528A patent/MXPA02005528A/es active IP Right Grant
- 2000-11-29 IL IL14988300A patent/IL149883A0/xx active IP Right Grant
- 2000-11-29 CZ CZ20021911A patent/CZ20021911A3/cs unknown
- 2000-11-29 YU YU50302A patent/YU50302A/sh unknown
- 2000-11-29 US US10/148,386 patent/US6589963B2/en not_active Expired - Fee Related
- 2000-11-29 NZ NZ519592A patent/NZ519592A/en unknown
- 2000-11-29 EP EP00979026A patent/EP1236719A4/en not_active Withdrawn
- 2000-11-29 AU AU16495/01A patent/AU782631C/en not_active Ceased
- 2000-12-01 TW TW089125558A patent/TWI286549B/zh not_active IP Right Cessation
- 2000-12-01 AR ARP000106345A patent/AR033349A1/es unknown
- 2000-12-01 CO CO00091985A patent/CO5440230A1/es not_active Application Discontinuation
-
2002
- 2002-05-28 IL IL149883A patent/IL149883A/en not_active IP Right Cessation
- 2002-05-31 NO NO20022600A patent/NO323922B1/no unknown
-
2003
- 2003-08-25 HK HK03106069A patent/HK1053657A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ519592A (en) | 2003-11-28 |
AU1649501A (en) | 2001-06-12 |
KR20020058079A (ko) | 2002-07-12 |
IL149883A (en) | 2007-03-08 |
YU50302A (sh) | 2006-01-16 |
NO20022600L (no) | 2002-08-05 |
EP1236719A1 (en) | 2002-09-04 |
US20030027836A1 (en) | 2003-02-06 |
MXPA02005528A (es) | 2002-09-02 |
WO2001040192A1 (fr) | 2001-06-07 |
NO323922B1 (no) | 2007-07-23 |
CN1402712A (zh) | 2003-03-12 |
KR100716525B1 (ko) | 2007-05-10 |
CZ20021911A3 (cs) | 2002-10-16 |
CO5440230A1 (es) | 2004-09-30 |
HUP0203431A2 (hu) | 2003-02-28 |
EP1236719A4 (en) | 2003-06-25 |
PL356769A1 (en) | 2004-07-12 |
IL149883A0 (en) | 2002-11-10 |
AU782631B2 (en) | 2005-08-18 |
AU782631C (en) | 2006-08-17 |
CA2393265A1 (en) | 2001-06-07 |
TWI286549B (en) | 2007-09-11 |
RU2256661C2 (ru) | 2005-07-20 |
NO20022600D0 (no) | 2002-05-31 |
HK1053657A1 (en) | 2003-10-31 |
HUP0203431A3 (en) | 2003-11-28 |
CN1215059C (zh) | 2005-08-17 |
US6589963B2 (en) | 2003-07-08 |
AR033349A1 (es) | 2003-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0016064A (pt) | Compostos heterocìclicos e seus sais e uso medicinal dos mesmos | |
TR200102805T2 (tr) | Glikokinaz aktivatörleri | |
BR0017050A (pt) | Oxazolidinonas suebstituìdas e seu emprego na área da coagulação do sangue | |
ES8705886A1 (es) | Un metodo para preparar un derivadode tiazolidin-diona | |
KR940019699A (ko) | 옥사졸리딘디온 유도체, 그의 제조방법 및 용도 | |
BR9916279A (pt) | Composto, composição farmacêutica, uso de um composto, métodos de tratar ou prevenir doenças do sistema endocrinológico e diabetes melittus não dependente de insulina em um paciente em necessidade deste, e de tratar glicose de resistência prejudicada (ifg) ou tolerância à glicose prejudica (igt) em um paciente em necessida deste, processo para a fabricação de um medicamento particular a ser usado no tratamento ou prevenção de doenças do sistema endocrinológico, e, métodos para preparar os compostos | |
RU2001131722A (ru) | 5-[4-(6-Метокси-1-метил-1Н-бензимидазол-2-илметокси)бензил]-тиазолидин-2,4 -ди он гидрохлорид, обладающий гипогликемической активностью | |
KR970027098A (ko) | 프로피오페논 유도체 및 이의 제조 방법 | |
BRPI0407506A (pt) | compostos para o tratamento de distúrbios metabólicos, seu uso e composição farmacêutica compreendendo os mesmos | |
TR200000223T2 (tr) | XA faktörünü engelleyen heterosiklik türevler | |
AR025449A1 (es) | Soluciones farmaceuticas de levosimendan | |
RU2005135441A (ru) | Соединения для лечения метаболических расстройств | |
WO2002030867A3 (en) | Drugs for diabetes | |
AR043259A1 (es) | Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello | |
KR970025615A (ko) | 암 전이 억제제 | |
EP1122255A4 (en) | CARBONIC ACID DERIVATIVES AND MEDICINES THAT CONTAIN THEM AS ACTIVE INGREDIENTS | |
BR0306880A (pt) | Derivados do ácido fenil(alquil)carboxìlico e derivados diÈnicos de fenilalquila heterocìclica e o uso dos mesmos como medicamentos com atividade de redução de glicose do soro e/ou de lipìdios no soro | |
KR940702491A (ko) | 옥사졸리돈 유도체 | |
MXPA04007183A (es) | Composicion farmaceutica para el control de la glucosa en sangre de pacientes con diabetes tipo 2. | |
BR0111199A (pt) | Compostos heterocìclicos | |
BR9915027A (pt) | Derivados de 1,3-diaril-2-piridin-2-il-3-(3-piridin-2-ilamino)-propanol susbtituìdos, processos para a sua preparação, medicamentos contendo estes compostos e seu emprego | |
RU2001118854A (ru) | Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний | |
BR0318533A (pt) | azolidinacarbonitrilas e seu uso como inibidores de dpp-iv | |
KR910015300A (ko) | 부스피론 : 수면 무호흡증의 치료용도 | |
KR890003378A (ko) | 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8,11,13,24 E 25 DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |